Medcaptain Medical Technology Co., Ltd.

深圳麦科田生物医疗技术股份有限公司

02041.HK

Develops and manufactures medical devices across life support, minimally invasive intervention, and in vitro diagnostics, sold to hospitals, clinics, testing facilities and home care users in over 140 countries, with products reaching ~90% of China's Grade 3A hospitals.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Leased property
• Social insurance & housing fund
• Product quality, advertising & consumers
• Intellectual property
• Medical, pharma & clinical trials
• Customer concentration
• Supplier concentration
• Distribution model
• Raw material and commodity prices
• Pricing policy and price changes
• Overseas markets and operations
• Particular sales arrangements
• Business changes and acquisitions
• Capacity and utilisation
• Losses and path to profitability
• Decline in revenue or profit
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Adverse change after the track record
• Non-IFRS measures and adjustments
• Material share-based payments
• Weighted voting rights
• Sanctioned countries and export controls